Shree Cement
SHREECEM NSE
Shree Cement
Construction F&ONSE: SHREECEM BSE: 500387 Cement
Key Fundamentals
MidcapCementConstructionMarket Cap
₹79,738 Cr
Volatility
Moderate
P/E Ratio
48.47
EBITDA
₹5,299 Cr
Return on Equity
7.5%
Debt to Equity
0.08
Book Value
₹6,448.74
EPS
₹582.58
52W High
₹30,285
52W Low
₹21,550
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 27.4%
Weaknesses
3- Stock is trading at 3.40 times its book value
- The company has delivered a poor sales growth of 9.08% over past five years.
- Company has a low return on equity of 8.23% over last 3 years.
Growth Rate
Revenue Growth
8.72% higher than
3Y
Net Income Growth
55.61% higher than
3Y
Cash Flow Change
-22.89% lower than
3Y
ROE
43.95% higher than
3Y
ROCE
53.37% higher than
3Y
EBITDA Margin (Avg.)
7.78% higher than
3Y
AI Analysis — Bull vs Bear
6d ago
AI opinion · based on fundamentals
Risk medium
Shree Cement has a market capitalisation of about ₹80,622 crore and trades at 49.3x earnings and 3.46x book value. Its return on equity has been 8% over the last year and over three years, down from an 11% ten-year average. The balance sheet is almost debt free, and trailing-twelve-month sales growth of 13% is faster than the 5% three-year CAGR. The stock has returned -22% over one year and -5% annualised over both three and five years.
Bull Case 8
- The company is almost debt free, so it carries little financial risk and can fund capacity expansion in a capital-intensive industry without heavy borrowing.
- Sales growth is speeding up. TTM sales growth of 13% is well above the 5% three-year compounded sales growth, which points to better volumes or pricing recently.
- Three-year compounded profit growth of 10% is double the 5% three-year sales growth, which suggests better cost control or operating leverage over that period.
- Ten-year compounded sales growth of 14% shows the company has scaled its business steadily over a full cement cycle.
- With a market cap of about ₹80,622 crore, Shree Cement is one of the larger players in an industry that is consolidating, where scale helps with cost efficiency and regional pricing.
- The stock has fallen 22% over one year and returned -5% annualised over five years. Some of the earlier valuation premium has come out of the share price, even though multiples are still high.
- The ten-year average ROE of 11% is above the current 8%. If utilisation and margins recover, returns could move back toward historical levels.
- The company keeps a dividend payout of 27.4% (0.67% yield) while staying almost debt free, so it returns cash to shareholders and still funds growth.
Bear Case 8
- A P/E of 49.3 is high next to an ROE of about 8%. It implies an earnings yield of roughly 2%, which leaves little room for error if growth disappoints.
- The stock trades at 3.46x book value while earning only 8.23% ROE over three years. Paying a premium to book for a business earning below a typical cost of equity is hard to justify on returns alone.
- Five-year compounded profit growth is -6% even though five-year sales grew at 9%, which shows margins shrank sharply over that period.
- ROE has fallen steadily, from 11% over ten years to 9% over five years and 8% over three years and last year. Capital efficiency is getting worse.
- Shareholders have lost money over long periods: -5% CAGR over three years, -5% over five years, and only 3% over ten years, despite 14% ten-year sales growth.
- Three-year compounded sales growth of 5% is well below the 14% ten-year CAGR, so the company's growth rate has slowed structurally.
- TTM profit growth of 10% trails TTM sales growth of 13%, so the recent revenue pickup is not yet turning into proportionally higher earnings.
- A dividend yield of 0.67% gives little income support at the current valuation, so returns depend mostly on earnings growth and on the valuation multiple holding up.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
1d ago
Neutral 1
- Q2 results board meeting Oct 23 Sep 17
Shree Cement has scheduled a board meeting for October 23 to consider its Q2 financial results. No expected metrics or other agenda items have been disclosed.
TL;DR: There is only one news item for Shree Cement right now: a routine notice that the board will meet on October 23 to review Q2 results. It contains no information about performance, demand, pricing or costs, so it doesn't show whether the trend is improving or getting worse. The Q2 numbers on October 23 will be the next real signal, especially cement realizations, volume growth and fuel cost trends.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,036 | 4,774 | 5,193 | 5,401 | 5,124 | 4,054 | 4,573 | 5,532 | 5,281 | 4,761 | 4,801 | 6,101 | 6,233 |
| Expenses | 4,091 | 3,888 | 3,930 | 3,979 | 4,197 | 3,441 | 3,608 | 4,103 | 3,948 | 3,787 | 3,853 | 4,717 | 4,961 |
| Operating Profit | 945 | 886 | 1,264 | 1,422 | 927 | 613 | 965 | 1,429 | 1,333 | 974 | 947 | 1,384 | 1,272 |
| OPM % | 19% | 19% | 24% | 26% | 18% | 15% | 21% | 26% | 25% | 20% | 20% | 23% | 20% |
| Other Income | 169 | 132 | 147 | 150 | 139 | 181 | 111 | 158 | 235 | 179 | 146 | 101 | 212 |
| Interest | 74 | 67 | 55 | 62 | 56 | 56 | 52 | 41 | 46 | 51 | 59 | 56 | 57 |
| Depreciation | 339 | 412 | 444 | 702 | 704 | 716 | 799 | 788 | 654 | 668 | 710 | 762 | 686 |
| PBT | 700 | 539 | 913 | 807 | 306 | 23 | 225 | 758 | 868 | 434 | 324 | 667 | 741 |
| Tax % | 18% | 17% | 23% | 16% | 9% | -229% | 14% | 24% | 26% | 29% | 17% | 21% | 28% |
| Net Profit | 572 | 447 | 702 | 676 | 278 | 77 | 194 | 575 | 644 | 310 | 268 | 528 | 531 |
| EPS in Rs | 159 | 124 | 195 | 187 | 77.22 | 21.19 | 53.6 | 159 | 178 | 85.51 | 73.92 | 146 | 147 |
Profit & Loss
| Particulars | Jun 2015 | Mar 2016 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6,259 | 5,514 | 8,594 | 9,833 | 12,555 | 12,868 | 13,560 | 15,010 | 17,852 | 20,404 | 19,283 | 20,943 | 21,896 |
| Expenses | 4,916 | 4,107 | 6,081 | 7,360 | 9,758 | 9,098 | 9,468 | 11,300 | 14,893 | 15,887 | 15,349 | 16,306 | 17,318 |
| Operating Profit | 1,344 | 1,407 | 2,513 | 2,473 | 2,797 | 3,771 | 4,091 | 3,710 | 2,960 | 4,517 | 3,934 | 4,638 | 4,577 |
| OPM % | 21% | 26% | 29% | 25% | 22% | 29% | 30% | 25% | 17% | 22% | 20% | 22% | 21% |
| Other Income | 102 | 673 | 362 | 389 | 69 | 263 | 426 | 544 | 459 | 598 | 589 | 661 | 637 |
| Interest | 121 | 76 | 129 | 135 | 248 | 291 | 251 | 216 | 263 | 258 | 205 | 212 | 223 |
| Depreciation | 925 | 828 | 1,215 | 899 | 1,472 | 1,808 | 1,262 | 1,146 | 1,661 | 1,897 | 3,007 | 2,794 | 2,826 |
| PBT | 401 | 1,176 | 1,531 | 1,827 | 1,146 | 1,934 | 3,004 | 2,892 | 1,495 | 2,959 | 1,312 | 2,293 | 2,166 |
| Tax % | -6% | 3% | 13% | 24% | 11% | 20% | 24% | 19% | 15% | 19% | 14% | 24% | — |
| Net Profit | 426 | 1,143 | 1,339 | 1,384 | 1,015 | 1,544 | 2,290 | 2,337 | 1,269 | 2,396 | 1,124 | 1,749 | 1,636 |
| EPS in Rs | 122 | 328 | 384 | 397 | 289 | 426 | 634 | 646 | 352 | 664 | 311 | 483 | 452 |
| Div. Payout % | 20% | 7% | 36% | 13% | 21% | 26% | 9% | 14% | 28% | 16% | 35% | 31% | — |
Balance Sheet
| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 36 | 36 | 36 | 36 | 36 | 36 | 36 |
| Reserves | 5,241 | 6,811 | 7,663 | 8,862 | 9,636 | 13,133 | 15,361 | 17,424 | 18,600 | 20,667 | 21,502 | 23,231 |
| Borrowings | 917 | 881 | 1,293 | 3,403 | 2,803 | 3,146 | 2,230 | 2,129 | 2,725 | 1,656 | 1,046 | 1,868 |
| Other Liabilities | 1,805 | 1,737 | 2,175 | 2,842 | 3,019 | 3,629 | 3,886 | 4,159 | 4,973 | 5,566 | 5,880 | 6,312 |
| Total Liabilities | 7,998 | 9,463 | 11,166 | 15,142 | 15,493 | 19,944 | 21,513 | 23,749 | 26,334 | 27,925 | 28,464 | 31,448 |
| Fixed Assets | 3,004 | 3,050 | 2,599 | 3,589 | 6,182 | 6,163 | 6,216 | 7,282 | 7,481 | 9,591 | 9,315 | 11,207 |
| CWIP | 511 | 264 | 710 | 1,427 | 1,129 | 1,197 | 997 | 1,054 | 2,797 | 1,930 | 3,796 | 1,466 |
| Investments | 1,662 | 3,030 | 4,042 | 5,434 | 2,286 | 6,358 | 8,500 | 9,033 | 8,683 | 7,556 | 7,849 | 10,272 |
| Other Assets | 2,820 | 3,118 | 3,814 | 4,691 | 5,896 | 6,227 | 5,800 | 6,380 | 7,373 | 8,848 | 7,504 | 8,503 |
| Total Assets | 7,998 | 9,463 | 11,166 | 15,142 | 15,493 | 19,944 | 21,513 | 23,749 | 26,334 | 27,925 | 28,464 | 31,448 |
Cash Flow
| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,239 | 1,566 | 2,202 | 1,879 | 2,080 | 3,973 | 4,254 | 2,668 | 2,569 | 3,347 | 4,920 | 3,794 |
| Investing | -990 | -1,265 | -2,048 | -3,595 | -720 | -5,590 | -2,651 | -2,143 | -2,405 | -1,418 | -3,726 | -3,714 |
| Financing | -259 | -271 | -167 | 1,726 | -1,276 | 1,581 | -1,233 | -849 | -277 | -1,710 | -1,296 | -110 |
| Net Cash Flow | -10 | 31 | -13 | 10 | 84 | -36 | 370 | -324 | -113 | 220 | -102 | -30 |
| Free Cash Flow | 115 | 832 | 922 | -648 | 158 | 2,433 | 3,125 | 459 | -710 | 178 | 837 | 1,979 |
| CFO/OP | 99 | 121 | 99 | 96 | 83 | 118 | 122 | 77 | 98 | 84 | 136 | 89 |
Ratios
| Particulars | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 28 | 22 | 14 | 17 | 30 | 31 | 18 | 19 | 25 | 23 | 27 | 32 |
| Inventory Days | 708 | 657 | 765 | 743 | 672 | 631 | 585 | 878 | 703 | 670 | 444 | 469 |
| Days Payable | 225 | 207 | 205 | 345 | 193 | 242 | 301 | 313 | 305 | 229 | 247 | 274 |
| Cash Conversion Cycle | 511 | 472 | 575 | 416 | 509 | 420 | 302 | 584 | 423 | 464 | 223 | 227 |
| Working Capital Days | 18 | 32 | 22 | 11 | 62 | 5 | -21 | -1 | -27 | 7 | -8 | -10 |
| ROCE % | 9% | 18% | 20% | 18% | 13% | 15% | 19% | 17% | 9% | 15% | 7% | 10% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shree Cement insights
70 extracted metrics + investor summaries across FY06–FY27.
Documents
1
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9h - Transcript of the Conference Call held on 6th May, 2026, relating to Financial Results of the Company for the quarter ended 31st March, 2026 9h - Transcript of the Conference Call held on 6th May, 2026, relating to Financial Results of the Company for the quarter ended 31st March, 2026
2
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 May - Newspaper Advertisement for publication of Financial results of the Company for the Quarter and Year ended 31st March, 2026 7 May - Newspaper Advertisement for publication of Financial results of the Company for the Quarter and Year ended 31st March, 2026
3
Board Meeting Outcome for Approval Of Audited Financial Results For The Quarter And Year Ended 31St March, 2026 And Recommendation Of Final Dividend
10h - FY26 audited results approved; Rs70 final dividend recommended; 3.5 MTPA Karnataka plant commissioned. 10h - FY26 audited results approved; Rs70 final dividend recommended; 3.5 MTPA Karnataka plant commissioned.
4
Financial Results For The Quarter And Year Ended 31St March, 2026
6 May - Board approved FY26 audited results, recommended Rs 70 dividend, and commissioned 3.5 MTPA Kodla cement plant. 6 May - Board approved FY26 audited results, recommended Rs 70 dividend, and commissioned 3.5 MTPA Kodla cement plant.
5
Announcement under Regulation 30 (LODR)-Press Release / Media Release
6 May - Shree Cement reported Q4FY26 results, commissioned 3.65 MTPA Kodla plant, and recommended ₹70 final dividend. 6 May - Shree Cement reported Q4FY26 results, commissioned 3.65 MTPA Kodla plant, and recommended ₹70 final dividend.
Frequently Asked Questions about Shree Cement
What does Shree Cement Ltd do?
Shree Cement is engaged in manufacturing and selling of cement and cement related products and is ** one of the lowest cost producers in the country. It is the 3rd largest** cement producer in India with an installed capacity of 46.4 MTPA. [1]
Where is Shree Cement Ltd (SHREECEM) listed?
Shree Cement Ltd trades as SHREECEM on the NSE and under code 500387 on the BSE.
Which sector does Shree Cement Ltd belong to?
Shree Cement Ltd is classified under the Construction sector, in the Cement industry.
What is the market capitalisation of Shree Cement Ltd?
Shree Cement Ltd has a market capitalisation of ₹79,738 Cr, which places it in the Large Cap band.
What is the PE ratio of Shree Cement Ltd?
Shree Cement Ltd trades at a PE ratio of 48.47, on earnings per share of ₹582.58, against a book value of ₹6,448.74 per share.
What is the 52-week high and low of Shree Cement Ltd?
Over the last 52 weeks Shree Cement Ltd has traded between ₹21,550 and ₹30,285.
Does Shree Cement Ltd pay dividends?
Shree Cement Ltd has a dividend yield of 0.67%.
What is the Return on Equity (ROE) of Shree Cement Ltd?
Shree Cement Ltd reported a return on equity of 7.50%. Its debt-to-equity ratio is 0.08.
Company Information
Shree Cement is engaged in manufacturing and selling of cement and cement related products and is ** one of the lowest cost producers in the country. It is the 3rd largest** cement producer in India with an installed capacity of 46.4 MTPA. [1]
Website shreecement.com
CEO Mr. Hari Mohan Bangur
Employees 7,022
Listed 1995-04-26
Face Value ₹ 10
Issued Size 3,60,80,748
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHREECEM.md for Shree Cement Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.